
Tyler-Davis Ogden
Chief Executive Officer
Tyler-Davis Ogden has spent more than a decade building and leading healthcare ventures, including founding a pioneering company in the amniotic allograft field. His work centers on wound healing, tissue repair, diabetes treatment and regenerative solutions, and on the systems required to deliver them consistently. He is a member of the Harvard Medical School Global Health Leaders Program.



